WebSep 15, 2009 · Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review T. Younis D. Rayson WebDec 6, 2014 · Methods: We constructed a Markov decision-analytic model to compare the strategy of secondary prophylaxis with G-CSF to a strategy of "no G-CSF" in response …
UpToDate
WebPatients were stratified into two groups: those who were given G-CSF for primary prophylaxis (n = 47) and for secondary prophylaxis (n = 38). G-CSF-included filgrastim or pegfilgrastim. The primary endpoints were incidence of febrile neutropenia and grade 3 or 4 neutropenia. Results: WebObjectives: The use of granulocyte colony-stimulating factors (G-CSF) during concurrent chemo-radiotherapy (cCTRT) for small cell lung cancer is not recommended by the … bosch benchmark she89pw55n
Granocyte-colony stimulating factor (G-CSF) has …
WebOct 1, 2011 · Thirteen patients (65%) received a total of 28 courses of G-CSF during thoracic RT (G-CSF RT group) with a median number of cycles of 2.1 (Table 3). Three patients received G-CSF as primary prophylaxis, 5 as part of the treatment of febrile neutropenia and 5 as secondary prophylaxis. Twelve (92%) of 13 patients received 4 … WebJun 1, 2024 · Recombinant human granulocyte colony stimulating factor (G-CSF) is commonly used as a primary or secondary prophylaxis to reduce the degree and duration of neutropenia in patients at risk of developing chemotherapy-induced neutropenic fever and infectious complications. G-CSF is known to decrease mortality and increase the … WebSep 28, 2024 · The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia. Med Oncol 2005; 22:229. Chouaid C, Bassinet L, Fuhrman C, et al. Routine … Medline ® Abstract for Reference 3 of 'Use of granulocyte colony stimulating factors … The impact of primary prophylaxis with granulocyte colony-stimulating factors … {{configCtrl2.info.metaDescription}} Medline ® Abstract for Reference 41 of 'Use of granulocyte colony stimulating factors … Medline ® Abstract for Reference 54 of 'Use of granulocyte colony stimulating factors … BACKGROUND The optimal duration of filgrastim as primary febrile neutropenia … RESULTS For the first cycle, the mean incremental costs of adding GCSF … UpToDate ... English ... Secondary end points were incidence of hospitalizations associated with a … Medline ® Abstract for Reference 2 of 'Use of granulocyte colony stimulating factors … bosch benchmark series induction cooktop 36